Publicacions (247) Publicacions de SAMUEL NAVARRO FOS Mostra dades de recerca referenciades.

filter_list Cancer%20Research

2025

  1. Data set for reporting of peripheral neuroblastic tumours: recommendations from the international collaboration on cancer reporting (ICCR)

    Histopathology

  2. High-risk neuroblastoma: ATRX and TERT as prognostic markers and therapeutic targets. Review and update on the topic

    Revista Espanola de Patologia, Vol. 58, Núm. 1

  3. Peripheral neuroblastic tumors behaving badly: an update on high-risk morphologic and molecular groupings

    Virchows Archiv

  4. Primary Visceral Ewing Sarcoma (Gastric and Bladder) with KIT Expression: A Report of Two Patients and a Differential Diagnostic Approach

    International Journal of Surgical Pathology

  5. Risk of developing neuroblastoma influenced by maternal stressful life events during pregnancy and congenital pathologies

    Pediatric Blood and Cancer, Vol. 72, Núm. 2

  6. Tackling ALT-positive neuroblastoma: is it time to redefine risk classification systems? A systematic review with IPD meta-analysis

    Neoplasia (United States), Vol. 60

2024

  1. Characterization of Vitronectin Effect in 3D Ewing Sarcoma Models: A Digital Microscopic Analysis of Two Cell Lines

    Cancers, Vol. 16, Núm. 19

  2. Decoding BCOR-ITD Sarcomas: Case Report of a Rare Pediatric Tumor With Challenges in Diagnosis

    Pediatric and Developmental Pathology, Vol. 27, Núm. 6, pp. 582-586

  3. Immunological Tumor Microenvironment of Solitary Fibrous Tumors—Associating Immune Infiltrate with Variables of Prognostic Significance

    Cancers, Vol. 16, Núm. 18

  4. Rare mediastinal small round cell melanoma with synovial sarcoma-like immunophenotype: A potential diagnostic pitfall

    Pathology Research and Practice, Vol. 262

  5. Real-time morphometric analysis of targeted therapy for neuroblastoma cells in monolayer and 3D hydrogels using digital holographic microscopy

    iScience, Vol. 27, Núm. 11

  6. Refining Risk Criteria May Substantially Reduce Unnecessary Additional Surgeries after Local Resection of T1 Colorectal Cancer

    Cancers, Vol. 16, Núm. 13

  7. SEAP-IAP recommendations for the collection, storage and use of biological materials of human origin and related data intended for research. Generic biobank consideration and ethical-legal review (Part II)

    Revista Espanola de Patologia, Vol. 57, Núm. 4, pp. 250-257

  8. Sarcomas with EWSR1::Non-ETS Fusion (EWSR1::NFATC2 and EWSR1::PATZ1)

    Surgical Pathology Clinics, Vol. 17, Núm. 1, pp. 31-55

  9. Solitary fibrous tumor: Can the new Huang risk stratification system for orbital tumors improve prognostic accuracy in other tumor locations?

    Pathology Research and Practice, Vol. 254

  10. The Combined Immunohistochemical Expression of GLI1 and BCOR in Synovial Sarcomas for the Identification of Three Risk Groups and Their Prognostic Outcomes: A Study of 52 Patients

    International Journal of Molecular Sciences, Vol. 25, Núm. 14

  11. The value of GLI1 and p16 immunohistochemistry in the premolecular screening for GLI1-altered mesenchymal neoplasms

    Virchows Archiv, Vol. 484, Núm. 5, pp. 765-775

  12. Vitronectin Levels in the Plasma of Neuroblastoma Patients and Culture Media of 3D Models: A Prognostic Circulating Biomarker?

    International Journal of Molecular Sciences, Vol. 25, Núm. 16

2023

  1. Acquired aggressive multisystemic disseminated lobular capillary haemangioma: a life threatening disorder

    Pathology

  2. Digital image analysis workflows for evaluation of cell behavior and tumor microenvironment to aid therapeutic assessment in high-risk neuroblastoma

    Computers in Biology and Medicine, Vol. 164